IP Library Granted Patent US 12,018,094
Granted Patent B2
US 12,018,094 · App. 18/086,203 · Granted Jun 25, 2024

Crystalline dipeptides useful in the synthesis of elamipretide

Inventors: Scott M. Duncan (Bedford, MA); Martin P. Redmon (Boston, MA)
Assignee: Stealth BioTherapeutics Inc.
C07K5/06095C07C237/20C07K5/06086C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,018,094
App. No.
18/086,203
Granted
Jun 25, 2024
Kind
B2
Abstract

Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH 2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.

Claims (31)

1. A crystalline form of a compound according to formula II:

2. A method of making a compound of formula II:

comprising:

(a) combining an HCl salt represented by formula I, and a mixture of CH 3 OH and H 2 O, thereby forming a suspension comprising the compound of Formula II; wherein the compound of formula I is:

3. The method of claim 2 , further comprising:

(b) heating the suspension, thereby forming a solution.

4. The method of claim 3 , wherein the suspension is heated to about 45° C. to about 50° C.

5. The method of claim 3 , further comprising:

(c) adding an aqueous solution of Na 2 CO 3 to the solution formed in (b), thereby forming a second suspension.

6. The method of claim 5 , wherein about 1.2 equivalents of Na 2 CO 3 is added relative to the amount of the compound of formula I.

7. The method of claim 5 , further comprising:

(d) stirring the second suspension.

8. The method of claim 7 , wherein the second suspension is heated to about 45° C. while being stirred.

9. The method of claim 8 , wherein the second suspension is stirred at about 45° C. for about one hour.

10. The method of claim 8 , further comprising:

(e) cooling the second suspension to about 15° C.

11. The method of claim 10 , wherein the second suspension is stirred at about 15° C. for about one hour.

12. The method of claim 10 , further comprising:

(f) isolating from the second suspension the compound of formula II in solid form.

13. The method of claim 12 , wherein (f) comprises filtering the second suspension, and collecting the solid form of the compound of formula II.

14. The method of claim 13 , further comprising:

(g) drying the compound of formula II, thereby forming a dried compound of formula II.

15. The method of claim 14 , wherein the dried compound of formula II has a purity of 99.4% as measured by HPLC.

16. The method of claim 14 , wherein the dried compound of formula II is crystalline.

17. A method of making a compound of formula II:

comprising:

(a) adding an aqueous solution of Na 2 CO 3 to a solution comprising an HCl salt represented by formula I and a mixture of CH 3 OH and H 2 O; wherein the HCl salt of formula I is:

thereby forming a suspension comprising the compound of Formula II.

18. The method of claim 17 , wherein about 1.2 equivalents of Na 2 CO 3 is added relative to the amount of the compound of formula I.

19. The method of claim 17 , further comprising:

(b) isolating from the suspension the compound of formula II in solid form, wherein the solid form of formula II has a purity of 99.4% as measured by HPLC.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2023
From: DUNCAN, SCOTT M.; REDMON, MARTIN P.
To: STEALTH BIOTHERAPEUTICS CORP.
Reel/Frame 064773/0634 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2023
From: STEALTH BIOTHERAPEUTICS CORP.
To: STEALTH BIOTHERAPEUTICS INC.
Reel/Frame 064801/0934 →
Continuity (4)
Continuation 17224353 · Apr 7, 2021
Division 16485369
Provisional Application 62651430 · Apr 2, 2018
Related Publication 20230203093A1 · Jun 29, 2023